Assembly Biosciences CSO Receives 14,000 RSUs Valued at $0 Per Share

William E. Delaney IV, Chief Scientific Officer of Assembly Biosciences, Inc., received 14,000 restricted stock units on March 29, 2026, with a value of $0 per share. These RSUs represent 35% of his annual equity grant and were contingent upon stockholder approval of an amendment to the company's 2018 Stock Incentive Plan, which was approved on June 4, 2026. The RSUs vest in four approximately equal installments over four years, starting March 29, 2027, and ending March 29, 2030, assuming continuous service. Following this transaction, Delaney holds 60,330 shares of common stock, which includes 688 shares acquired through the Employee Stock Purchase Plan. The filing was signed by attorney-in-fact John O. Gunderson on June 5, 2026.